Hansa Biopharma AB (OSTO:HNSA)
kr 40.5 3 (8%) Market Cap: 2.66 Bil Enterprise Value: 3.06 Bil PE Ratio: 0 PB Ratio: 0 GF Score: 77/100

Q1 2019 Hansa Biopharma AB Earnings Call Transcript

Apr 29, 2019 / 12:00PM GMT
Operator

Ladies and gentlemen, welcome to the Hansa Biopharma Teleconference Q1 2019 Call. Today, I'm pleased to present Søren Tulstrup, President and CEO. (Operator Instructions) Søren, please begin your meeting.

SÃ;ren Tulstrup
Hansa Biopharma AB - President & CEO

¸ -

Thank you, operator. Hello, I'm Søren Tulstrup, President and CEO of Hansa Biopharma. Welcome to Hansa Biopharma's conference call on the results for the first quarter of 2019.

Please turn to Slide 2. Please allow me to draw your attention to the forward-looking statements, which apply to this presentation.

Please turn to Slide 3. I'm joined here today by Eva-Maria Joed, Vice President and Chief Financial Officer. As previously communicated, Donato Spota will be starting as our new Chief Financial Officer in May, so he will be taking over from Eva-Maria at our next quarterly results call. Eva-Maria will be working closely with Donato in her new role as Vice President of Finance and Administration.

Also, I'm pleased to welcome Klaus Sindahl as our new Head

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot